Our analysis showed that only one study investigated the dose of G-CSF and its efficacy in humans with stroke (Sprigg et al., 2006), whereas no studies investigated CSF in stroke with other conditions such as stroke complications, CSF administration, and baseline characteristics of patients (e.g. age, smoke, alcohol abuse). Here, CSF3 is linked to stroke disorder.